Anticancer Peptide MCP-1 Induces Ferroptosis in Liver Cancer HCCLM3 Cells by Targeting FOXM1/ALOXE3 Signal Pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anticancer Peptide MCP-1 Induces Ferroptosis in Liver Cancer HCCLM3 Cells by Targeting FOXM1/ALOXE3 Signal Pathway

Published:2024-05-10 Issue:4 Volume:30 Page:
ISSN:1573-3904
Container-title:International Journal of Peptide Research and Therapeutics
language:en
Short-container-title:Int J Pept Res Ther

Author:

Zhu Fanyue,Shang Zhixian,Jia Shijie,Jiang Yuhong,Chang Miao,Liang Anping,Hua Xinyi,Mao Canquan

Funder

National Natural Science Foundation of China

the Key Research and Development Project of Chengdu

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10989-024-10614-w.pdf

Reference38 articles.

1. Barger CJ, Branick C, Chee L, Karpf AR (2019) Pan-cancer analyses reveal genomic features of FOXM1 overexpression in Cancer. Cancers (Basel) 11(2):251. https://doi.org/10.3390/cancers11020251

2. Bella L, Zona S, Nestal de Moraes G, Lam EW-F (2014) FOXM1: a key oncofoetal transcription factor in health and disease. Semin Cancer Biol 29:32–39. https://doi.org/10.1016/j.semcancer.2014.07.008

3. Bi Z, Liu W, Ding R, Wu Y, Dou R, Zhang W, Yuan X, Liu X, Xiong L, Guo Z, Mao C (2017) A novel peptide, 9R-P201, strongly inhibits the viability, proliferation and migration of liver cancer HepG2 cells and induces apoptosis by down-regulation of FoxM1 expression. Eur J Pharmacol 796:175–189. https://doi.org/10.1016/j.ejphar.2016.12.029

4. Chen Y, Li H (2022) Prognostic and predictive models for left- and right- colorectal Cancer patients: a Bioinformatics Analysis based on ferroptosis-related genes. Front Oncol 12:833834. https://doi.org/10.3389/fonc.2022.833834

5. Chen X, Kang R, Kroemer G, Tang D (2021) Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol 18(5):280–296. https://doi.org/10.1038/s41571-020-00462-0

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3